Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiother Oncol 2020; 150:62-69.
12.06.2020
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
12.06.2020
Radiother Oncol 2020; 150:62-69
Riesterer Oliver, Pruschy Martin, Bender Sabine, Sharma Ashish, Bogowicz Marta, Tanadini-Lang Stephanie, Stieb Sonja, Bertogg Kaja, Weber Sandra, Ikenberg Kristian, Huber Gerhard, Schmid Stephan, Bredell Marius, Veit-Haibach Patrick, Rordorf Tamara, Held Ulrike, Glanzmann Christoph, Studer Gabriela
Weiter